During regular trading hours, there were many stocks that continued to break up to the upside. These stocks are usually going up with news.If you are looking to day trade Also check out my Top 2011 Stock Gainers, Stocks to Buy 2011.You can also check previous stocks to buy reports- Right Here today.Hot stocks Today Right Here.I also have technical analysis different stocks-Right Here. Market Technical analysis Right Here
Quick Look Market Closing Price:
At the close: Dow -0.63% to 11474. S&P -0.41% to 1188. Nasdaq +0.23% to 2216.
Treasurys: 30-year +0.56%. 10-yr +0.21%. 5-yr +0.174%.
Commodities: Crude +0.97% to $97.86. Gold +1.27% to $1699.95.
Currencies: Euro +0.17% vs. dollar. Yen +0.12%. Pound +0.01%
After Hours Earning News:
TiVo (TIVO): Q3 EPS of -$0.21 beats by $0.02. Revenue of $65M (+25.4% Y/Y) beats by $14M. Shares +2.6% AH.
Pandora Media (P): FQ3 EPS of $0.02 beats by $0.03. Revenue of $75M (+99% Y/Y) beats by $3.6M. Claims it had 4.3% share of U.S. radio listening, up from 3.6% in FQ2. Company expects FQ4 revenue of $80M-$84M vs. $82.3M consensus. Expects EPS of -$0.04 to -$0.02 vs. -$0.02 consensus. Shares -2.5% AH.
Pandora Media (P): FQ3 EPS of $0.02 beats by $0.03. Revenue of $75M (+99% Y/Y) beats by $3.6M. Claims it had 4.3% share of U.S. radio listening, up from 3.6% in FQ2. Company expects FQ4 revenue of $80M-$84M vs. $82.3M consensus. Expects EPS of -$0.04 to -$0.02 vs. -$0.02 consensus. Shares -2.5% AH.
Celgene (CELG) drops 1.8% AH after stating it will discontinue Phase III trials for evaluating the use of its Revlimid drug to help treat prostate cancer.
Nuance Communications (NUAN): FQ4 EPS of $0.42 beats by $0.01. Revenue of $400M (+23% Y/Y) beats by $7M. Shares -1.3% AH
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/
